Antithrombotic amides

This application relates to a compound of formula I (or a pharmaceutically acceptable salt thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.

Saved in:
Bibliographic Details
Main Authors JOSEPH SAJAN, BEIGHT DOUGLAS WADE, WIKEL JAMES HOWARD, CRAFT TRELIA JOYCE, TINSLEY JENNIFER MARIE, PINEIRO-NUNEZ MARTA MARIA, FRANCISKOVICH JEFFRY BERNARD, WILEY MICHAEL ROBERT, MENDEL DAVID, SAWYER JASON SCOTT, YEE YING KWONG, GOODSON, JR. THEODORE, KYLE JEFFREY ALAN, SMITH GERALD FLOYD, TEBBE ANNE LOUISE, WEIR LEONARD CRAYTON, SHUMAN ROBERT THEODORE, HALL STEVEN EDWARD, HERRON DAVID KENT, MASTERS JOHN JOSEPH, MILOT GUY, KLIMKOWSKI VALENTINE JOSEPH
Format Patent
LanguageEnglish
Published 24.08.2004
Edition7
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:This application relates to a compound of formula I (or a pharmaceutically acceptable salt thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.
Bibliography:Application Number: US20030382614